 ClearPoint Neuro Inc NASDAQ: CLPT reported Q2 revenue of 3.4 million, a 38 YY increase, below the consensus estimate of 3.68 million. Functional neurosurgery navigation revenue increased 74 to 1.9 million, reflecting the resumption of elective surgical procedures. 